(Q33528298)

27 July 2017

title

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients (English)

1 reference

Agnieszka Dansonka-Mieszkowska

27 July 2017

0 references

1 reference

1

object named as

Agnieszka Dansonka-Mieszkowska

0 references

Jolanta Kupryjanczyk

9

object named as

Jolanta Kupryjanczyk

0 references

Michalina Dabrowska

4

object named as

Michalina Dabrowska

1 reference

27 July 2017

2

Anna Kluska

1 reference

27 July 2017

7

Pawel Derlatka

1 reference

27 July 2017

6

Anna Niwinska

1 reference

27 July 2017

Joanna Moes

3

1 reference

27 July 2017

Dorota Nowakowska

5

1 reference

27 July 2017

Krzysztof Cendrowski

8

1 reference

27 July 2017

publication date

2 February 2010

1 reference

27 July 2017

1 reference

27 July 2017

volume

11

1 reference

27 July 2017

page(s)

20

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2350-11-20

27 July 2017

exact match

0 references

cites work

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

PALB2 regulates recombinational repair through chromatin association and oligomerization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

PALB2 links BRCA1 and BRCA2 in the DNA-damage response

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

The Fanconi anemia pathway and ubiquitin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Analysis of PALB2/FANCN-associated breast cancer families

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Geographical variations in TP53 mutational spectrum in ovarian carcinomas.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Molecular pathogenesis of Fanconi anemia: recent progress

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829009

A recurrent mutation in PALB2 in Finnish cancer families.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2350-11-20

The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2350-11-20

Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2350-11-20

The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20122277

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

SSCP analysis: A blind sensitivity trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20122277

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20122277

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2350-11-20

1 reference

27 July 2017

1 reference

27 July 2017

1 reference